Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 709736, 9 pages
http://dx.doi.org/10.1155/2014/709736
Review Article

Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer

1Second Department of Obstetrics and Gynecology, University of Athens Medical School, Aretaieion University Hospital, 76 Vas. Sofias Avenue, 11527 Athens, Greece
2Department of Gynecology and Obstetrics, The Johns Hopkins Hospital School of Medicine, Baltimore, MD 21287, USA

Received 30 August 2013; Accepted 9 October 2013; Published 12 January 2014

Academic Editors: D. H. Dinh, E. K. Han, D. G. Mutch, and E. O. Pettersen

Copyright © 2014 Athanasia Pavlidou and Nikos F. Vlahos. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [24 citations]

The following is the list of published articles that have cited the current article.

  • Salvatore Lopez, Carlton L. Schwab, Emiliano Cocco, Stefania Bellone, Elena Bonazzoli, Diana P. English, Peter E. Schwartz, Thomas Rutherford, Roberto Angioli, and Alessandro D. Santin, “Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivo,” Gynecologic Oncology, 2014. View at Publisher · View at Google Scholar
  • Ewa Wandzioch, Michelle Pusey, Amy Werda, Sophie Bail, Aishwarya Bhaskar, Mariya Nestor, Jing-Jing Yang, and Lyndi M. Rice, “PME-1 Modulates Protein Phosphatase 2A Activity to Promote the Malignant Phenotype of Endometrial Cancer Cells,” Cancer Research, vol. 74, no. 16, pp. 4295–4305, 2014. View at Publisher · View at Google Scholar
  • Lynn Verstrepen, and Rudi Beyaert, “Receptor proximal kinases in NF-κB signaling as potential therapeutic targets in cancer and inflammation,” Biochemical Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Robert L. Coleman, Michael W. Sill, Premal H. Thaker, David P. Bender, Daron Street, William P. McGuire, Carolyn M. Johnston, and Jacob Rotmensch, “A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial can,” Gynecologic Oncology, vol. 138, no. 1, pp. 30–35, 2015. View at Publisher · View at Google Scholar
  • Ji Yeon Lim, Joo Yun Lee, Byung Jin Byun, and Seong Hwan Kim, “Fisetin Targets Phosphatidylinositol-3-kinase and Induces Apoptosis of Human B Lymphoma Raji Cells,” Toxicology Reports, 2015. View at Publisher · View at Google Scholar
  • Chun-Mei Yan, Er-Qing Chai, Hong-Yi Cai, Guo-Ying Miao, and Wen Ma, “Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepat,” Molecular Medicine Reports, vol. 11, no. 6, pp. 4617–4624, 2015. View at Publisher · View at Google Scholar
  • Jesse Lopes da Silva, Eduardo Paulino, Mariane Fontes Dias, and Andréia Cristina de Melo, “Endometrial cancer: redefining the molecular-targeted approach,” Cancer Chemotherapy and Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Min Li, Xiaoyan Xin, Tingting Wu, Teng Hua, Hongbin Wang, and Hongbo Wang, “Stromal cells of endometrial carcinoma promotes proliferation of epithelial cells through the HGF/c-Met/Akt signaling pathway,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Zhihua Wang, Fengle Ma, Juan Wang, Zeyuan Zhou, Baogang Liu, Xinyao He, Lei Fu, Wenxi He, and Paul R. Cooper, “Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signaling Are Required for Lipopolysaccharide-mediated Mineralization in Murine Odontoblast-like Cells,” Journal of Endodontics, 2015. View at Publisher · View at Google Scholar
  • Salvatore Lopez, Emiliano Cocco, Jonathan Black, Stefania Bellone, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Carlton L. Schwab, Diana P. English, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Corrado Terranova, Roberto Angioli, and Alessandro D. Santin, “Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo,” Molecular Cancer Therapeutics, vol. 14, no. 11, pp. 2519–2526, 2015. View at Publisher · View at Google Scholar
  • Huiqiao Gao, and Zhenyu Zhang, “Systematic Analysis of Endometrial Cancer-Associated Hub Proteins Based on Text Mining,” BioMed Research International, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Helga Weber, Juan C. Araya, Manuel Grez, Juan C. Roa, Pamela Leal, Stefan Stein, Hana Kunkel, Patricia García, Carolina Bizama, Jaime A. Espinoza, Ismael Riquelme, and Bruno Nervi, “Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice,” Oncotarget, vol. 6, no. 31, pp. 31877–31888, 2015. View at Publisher · View at Google Scholar
  • R. Pinto-Leite, R. Arantes-Rodrigues, Nuno Sousa, P. A. Oliveira, and L. Santos, “mTOR inhibitors in urinary bladder cancer,” Tumor Biology, 2016. View at Publisher · View at Google Scholar
  • Yaping Zhu, Jiaqi Shen, Liyan Gao, and Youji Feng, “Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signali,” Oncology Reports, vol. 35, no. 4, pp. 2391–2397, 2016. View at Publisher · View at Google Scholar
  • C. N. Kent, and I. K. Guttilla Reed, “Regulation of epithelial–mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs,” Clinical and Translational Oncology, 2016. View at Publisher · View at Google Scholar
  • Nuria Eritja, Andree Yeramian, Bo-Juen Chen, David Llobet-Navas, Eugenia Ortega, Eva Colas, Miguel Abal, Xavier Dolcet, Jaume Reventos, and Xavier Matias-Guiu, “Endometrial Carcinoma: Specific Targeted Pathways,” Molecular Genetics of Endometrial Carcinoma, vol. 943, pp. 149–207, 2016. View at Publisher · View at Google Scholar
  • Yonggang Yao, Di Yang, Yu Han, Wei Wang, Na Wang, Jian Yang, and Chunyu Zeng, “Dopamine D-1-Like Receptors Suppress the Proliferation of Macrophages Induced by Ox-LDL,” Cellular Physiology And Biochemistry, vol. 38, no. 1, pp. 415–426, 2016. View at Publisher · View at Google Scholar
  • Chao Zhang, Yao Chen, Xiangdong Gan, Zhiguang Huang, Minji Zou, Wenliang Fu, Weiwei Xing, and Donggang Xu, “SAK-HV Decreases the Self-Ubiquitination of MEKK1 to Promote Macrophage Proliferation via MAPK/ERK and JNK Pathways,” International Journal of Molecular Sciences, vol. 18, no. 4, pp. 835, 2017. View at Publisher · View at Google Scholar
  • Yifang Zhang, Lili Zhang, Hengzi Sun, Qingtao Lv, Chunping Qiu, Xiaoxia Che, Zhiming Liu, and Jie Jiang, “Forkhead transcription factor 1 inhibits endometrial cancer cell proliferation via sterol regulatory element‑binding protein 1,” Oncology Letters, vol. 13, no. 2, pp. 731–737, 2017. View at Publisher · View at Google Scholar
  • Suxia Zhang, Min Wang, Qirong Li, and Ping Zhu, “MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR,” Cancer Biomarkers, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Xiaohui Yan, Miao Qi, Pengfei Li, Yihong Zhan, and Huanjie Shao, “Apigenin in cancer therapy: anti-cancer effects and mechanisms of action,” Cell & Bioscience, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Xinchao Deng, Congzhe Hou, Zhen Liang, Huali Wang, Lin Zhu, and Hui Xu, “miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma,” Disease Markers, vol. 2017, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Z.B. Cincin, B. Kiran, Y. Baran, and B. Cakmakoglu, “Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells,” Biomedicine & Pharmacotherapy, vol. 103, pp. 336–345, 2018. View at Publisher · View at Google Scholar
  • Yuping Du, Lili Wang, Shuo Chen, Yao Liu, and Yang Zhao, “lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR,” Molecular Carcinogenesis, 2018. View at Publisher · View at Google Scholar